Status:
COMPLETED
Retrospective Study in a NSCLC M+ p
Lead Sponsor:
AstraZeneca
Conditions:
EGFR Mutated Non-small Cell Lung Cancer Patients
Eligibility:
All Genders
18+ years
Brief Summary
This is a national, multicentre, non-interventional, retrospective study to be carried out in the oncology settings of approximately 15-20 Spanish hospitals. At each participant hospital, all patient...
Detailed Description
Observational retrospective study to describe the management of advanced or metastatic EGFR mutated non-small cell lung cancer patients in Spain
Eligibility Criteria
Inclusion
- Histologically or cytologically confirmed newly locally advanced or metastatic NSCLC (stage IIIB/IV)
- Confirmed EGFR mutation by a validated test
- Availability of medical record
Exclusion
- Participating on a blinded randomized clinical trial at any time during the study period
- Pregnant women (due to they do not reflect daily clinical practice)
Key Trial Info
Start Date :
March 1 2013
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
October 1 2013
Estimated Enrollment :
187 Patients enrolled
Trial Details
Trial ID
NCT01795352
Start Date
March 1 2013
End Date
October 1 2013
Last Update
October 30 2013
Active Locations (12)
Enter a location and click search to find clinical trials sorted by distance.
1
Research Site
Barcelona, Barcelona, Spain
2
Research Site
Córdoba, Cordoba, Spain
3
Research Site
Donostia / San Sebastian, Donostia, Spain
4
Research Site
Granada, Granada, Spain